Streamlining the Journey to a Cure: Optimizing the Hepatitis C Virus Care Cascade is organized by CME Outfitters, LLC.
Live Webcast: Wednesday, July 8, 2020 | 6:30 PM - 8:00 PM ET
Credit Expiration Date: Thursday, July 8, 2021
This activity offers CE credit for:
• Physicians (CME)
• Nurses (CNE)
• Pharmacists (ACPE)
• ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Statement of Need:
Hepatitis C virus (HCV) is a major cause of cirrhosis, liver cancer, and mortality worldwide. The opioid crisis has caused a rise in injection drug use, which has contributed significantly to the increase in HCV infections. The United States experienced a 238% increase in new HCV infections between 2010 and 2016, which has led to a goal to eliminate hepatitis by treating 80% of patients with hepatitis B virus (HBV) and HCV by 2030. The American Association for the Study of Liver Diseases/Infectious Disease Society of America (AASLD/IDSA) guidelines aim to achieve this with universal, one-time screening of all individuals over 18 for HCV, with individuals at increased risk (e.g., people who inject drugs [PWID]) screened more frequently, as well as universal testing of pregnant women at the initiation of prenatal care.
Once diagnosed, treatment with currently available direct-acting antivirals (DAAs) is strongly recommended for all persons with chronic HCV infection. However, recent studies have shown persistent gaps in the HCV care continuum, with underdiagnosis and undertreatment being the major barriers toward achieving the goal of eliminating HCV. With primary care clinicians and community health workers representing an important front-line resource for early screening and treatment for HCV infection, it is imperative to educate primary care providers (PCPs) and community health workers to expand the HCV workforce and linkage-to-care opportunities.
This CME Outfitters live and on-demand webcast will feature expert faculty hosting an interactive discussion on implementing HCV screening, developing new methods of coordinated care, and addressing barriers to treatment access.
At the end of this CE activity, participants should be able to:
• Implement HCV screening for all adults and at-risk populations and women including PWID and women who are pregnant, in alignment with AASLD guidance.
• Develop new methods of PCP/specialist coordinated care to minimize gaps in linkage to care and optimize the HCV care cascade.
• Address barriers to access to treatment, such as stigma and HCP perceptions about substance use and PWID.
The following learning objectives pertain only to those requesting CNE or CPE credit:
• Explain HCV screening guidelines for all adults and at-risk populations including PWID and women who are pregnant, in alignment with AASLD guidance.
• Identify new methods of PCP/specialist coordinated care to minimize gaps in linkage to care and optimize the HCV care cascade.
• Describe barriers to access to treatment, such as stigma and HCP perceptions about substance use and PWID.
Primary care physicians, PAs, nurse practitioners, nurses, and pharmacists
Activity Payment Details
Reviews Given by Professionals
Browse by Specialty (Online CME/CE Only) View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Immunology and Microbiology
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine